Subject Expert Committee recommends DCGI to remove the Clinical Trial tag from Covaxin
The Subject Expert Committee (SEC) recommends DCGI to remove the Clinical Trial tag from Covaxin by Bharat Biotech which is Whole Virion, Inactivated Corona Virus Vaccine. And prior granted by DCGI under restricted use in emergency situation conditions.
Recommendations of the SEC meeting to examine COVID-19 related proposal under accelerated approval process made in its 146th meeting held on 10.03.2021 at CDSCO, HQ New Delhi.










